About Catapult Network
Catapult Network is a company based in London (United Kingdom) founded in 2013. The company has 377 employees as of March 31, 2021. Catapult Network offers products and services including R&D Facilities and Collaboration Support. Catapult Network operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter London, United Kingdom
- Employees 377 as on 31 Mar, 2021
-
Sectors
Business Services
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Digital Catapult
- Date of Incorporation 24 Feb, 2012
- Jurisdiction LONDON
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$15.14 M (USD), Grant
Nov 28, 2023
-
Investors
Gov.uk
& 1 more
-
Employee Count
377
as on Mar 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Catapult Network
Catapult Network offers a comprehensive portfolio of products and services, including R&D Facilities and Collaboration Support.
Offers access to cutting-edge research facilities for business innovation
Facilitates academia-industry collaborations for technology development
Funding Insights of Catapult Network
Investors in Catapult Network
Catapult Network has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Gov.uk and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Online government services and information are provided to users.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Catapult Network
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Catapult Network
Investment portfolio details for Catapult Network
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Catapult Network
Detailed financials for Catapult Network
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Catapult Network Comparisons
Peer comparison for Catapult Network
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Catapult Network
Catapult Network operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Catapult Network
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Catapult Network
Complete news archive for Catapult Network
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Catapult Network
Catapult Network was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Catapult Network is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
As of Mar 31, 2021, the latest employee count at Catapult Network is 377.
Catapult Network was founded in 2013 and is based in London, United Kingdom. Operations focus on advanced manufacturing, cell and gene therapy research, and entrepreneurial support within the innovation sector. Services encompass transport systems, urban innovation, semiconductor research, digital economy initiatives, satellite applications, and offshore renewable energy. These offerings support research and development activities across various industries.
Catapult Network's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Catapult Network offers R&D Facilities and Collaboration Support.
Catapult Network has 2 investors. Key investors include Gov.uk, and European Union.